tiprankstipranks
Trending News
More News >
Ocular Therapeutix Inc (OCUL)
NASDAQ:OCUL

Compare Ocular Therapeutix (OCUL) vs. Competitors

Compare
1,523 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ocular Therapeutix
$11.27
$2.40B
-7.85
40.00%
8 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$31.22
$3.17B
-7.04
33.42%
10 Buy
3 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$71.14
$3.02B
-35.33
51.62%
6 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$10.63
$1.05B
-13.12
-12.73%
4 Buy
0 Hold
0 Sell
Strong Buy
Belite Bio, Inc. ADR
$155.11
$5.41B
-80.79
192.44%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCUL
Ocular Therapeutix
11.27
3.18
39.31%
ETNB
BEAM
Beam Therapeutics
31.22
6.69
27.27%
TARS
Tarsus Pharmaceuticals
71.14
24.40
52.20%
SPRY
ARS Pharmaceuticals
10.63
-2.85
-21.14%
BLTE
Belite Bio, Inc. ADR
155.11
96.89
166.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts